Ventec Life Systems and Parachute Health Announce Digital Partnership

Streamlines Access to Integrated Respiratory Care for Ventilator Patients

Ventec Life Systems, a global medical device company focused on redefining respiratory care technologies for patients and caregivers announced today that Parachute Health’s ePrescribing platform now supports the VOCSN group of ventilators.

“Streamlining care for patients is at the heart of Ventec Life Systems, and we are proud to support innovative technology such as the Parachute Platform to provide greater access to the benefits of integrated respiratory care provided through the VOCSN group of ventilators,” said Jim Alwan, President and Chief Executive Officer of Ventec Life Systems. “And with the addition of our V+Pro ventilator to our product portfolio, billable under reimbursement codes E0465 and E0466, providers have access to alternative respiratory products which they have not had before.”

 

 

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version